GLISITAPTIN 100:Side effects, uses,Benefits, interactions, and alternatives

May 15, 2024

GLISITAPTIN 100

Sitagliptin Phosphate (100mg)

GLISITAPTIN 100 combination of Sitagliptin Phosphate (100mg), marketed under the brand name GLISITAPTIN 100, stands as a promising medication for addressing type 2 diabetes mellitus. This article aims to explore the therapeutic benefits, mechanism of action, potential side effects, and clinical considerations associated with Sitagliptin Phosphate (100mg) therapy.

Understanding Sitagliptin Phosphate (100mg):

  • Mechanism of Action: Sitagliptin Phosphate (100mg) is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which increases the levels of incretin hormones GLP-1 and GIP. This action stimulates insulin secretion and reduces glucagon release, leading to improved glycemic control.

Therapeutic Benefits of GLISITAPTIN 100:

  • Effective Glycemic Control: GLISITAPTIN 100 helps lower blood glucose levels by enhancing insulin secretion in a glucose-dependent manner, thereby reducing hyperglycemia.

  • Weight Neutrality: Unlike some other antidiabetic medications, Sitagliptin Phosphate (100mg) is weight-neutral and does not typically cause weight gain, making it suitable for patients concerned about weight management.

Clinical Considerations:

  • Renal Function Monitoring: Since Sitagliptin is mainly excreted via the kidneys, renal function should be monitored regularly during GLISITAPTIN 100 therapy.

  • Hypoglycemia Risk: GLISITAPTIN 100 has a low risk of causing hypoglycemia when used as monotherapy. 

Adverse Effects:

  • Common Side Effects: The most commonly reported side effects of Sitagliptin Phosphate (100mg) include upper respiratory tract infections, headache, and nasopharyngitis. 

Conclusion:

Sitagliptin Phosphate (100mg), also known as GLISITAPTIN 100, offers an effective and well-tolerated option for individuals with type 2 diabetes mellitus. By understanding its mechanism of action, therapeutic benefits, and clinical considerations, healthcare providers can optimize the use of Sitagliptin Phosphate (100mg) to achieve optimal glycemic control and improve patient outcomes.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW

SHARE WITH